| Name | Title | Contact Details |
|---|
Northfield Hospital and Clinics is an independent, integrated health care organization providing a wide range of healthcare services to patients throughout the southern metro region. Northfield Hospital and Clinics’ regional approach is designed to extend primary care services throughout the area and provide the patient base necessary to develop important specialty practices, such as cardiology and oncology, and make them more accessible to area residents. Our individual clinics include the primary and specialty care FamilyHealth Clinics located in Lonsdale, Northfield, Farmington, Elko New Market and Lakeville. The Northfield Hospital and Clinics network also features specialty clinics, including Women’s Health Center, Orthopaedic and Fracture Clinic, and Northfield Eye Physicians and Surgeons. Become an exceptional healthcare system and the provider of choice in the region.Northfield Hospital and Clinics provides a wide spectrum of medical services to residents of Rice, Dakota, Scott and Goodhue counties. Combining advanced technology with personalized, patient-centered care, we strive to create a healing environment where patients feel safe, secure and supported.
BeneChill is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ABC Medical Management is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Blueprint Medicines is developing a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients with genomically defined diseases. Our approach is rooted in a deep understanding of the genetic blueprint of cancer and other diseases driven by the abnormal activation of kinases. Our ability to identify novel drivers of disease, coupled with our proprietary library of novel and diverse chemical compounds, uniquely enables us to craft kinase therapies against new and difficult-to-drug targets. We are boldly advancing a deep pipeline of highly targeted therapies against previously unaddressed drivers of disease. By focusing on genomically defined subsets of patients, we believe we can identify the people most likely to respond to our therapies, resulting in a more efficient clinical development path with a greater likelihood of success and better outcomes for patients. We see a substantial opportunity in kinase drug discovery and development to deliver breakthrough medicines that allow patients to live longer with better quality of life and prevent recurrences of disease. Kinases are involved in many hallmarks of tumor biology and are proven cancer drug targets. Currently approved drugs focus on less than 5 percent of known kinases, and the function of most kinases is unknown. Led by a team of industry innovators with a track record of bringing life-changing drugs to market, we believe Blueprint Medicines has the experience and expertise to deliver on the tremendous untapped potential of kinase therapies to improve patients’ lives. We don’t think in small steps. We think in giant leaps. We are driven by the pursuit of new ideas, new innovations, and new ways of thinking.
Accent On Health At Latham Inc is a Latham, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.